GLP-1R agonist (Fukang)

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NameGLP-1R agonist (Fukang)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsSubstance-Related DisordersSclerosisDiabetes Mellitus, Type 2 +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Fukang Pharmaceutical Co LtdConvalife (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesConvalife (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsSubstance-Related DisordersSclerosisDiabetes Mellitus, Type 2 +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A